The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Cholangiocarcinoma: Epidemiology and risk factors
Open accessAbstract
Cholangiocarcinoma (CCA) is a heterogeneous disease arising from a complex interaction between host‐specific genetic background and multiple risk factors. Globally, CCA incidence rates exhibit geographical variation, with much higher incidence in parts of the Eastern world compared to the West. These differences are likely to reflect differences in geographical risk factors as well as genetic determinants. Of note, over the past few decades, the incidence rates of CCA appear to change and subtypes of CCA appear to show distinct epidemiological trends. These trends need to be interpreted with caution given the issues of diagnosis, recording and coding of subtypes of CCA. Epidemiological evidences suggest that in general population some risk factors are less frequent but associated with a higher CCA risk, while others are more common but associated with a lower risk. Moreover, while some risk factors are shared by intrahepatic and both extrahepatic forms, others seem more specific for one of the two forms. Currently some pathological conditions have been clearly associated with CCA development, and other conditions are emerging; however, while their impact in increasing CCA risk as single etiological factors has been provided in many studies, less is known when two or more risk factors co‐occur in the same patient. Moreover, despite the advancements in the knowledge of CCA aetiology, in Western countries about 50% of cases are still diagnosed without any identifiable risk factor. It is therefore conceivable that other still undefined etiologic factors are responsible for the recent increase of CCA (especially iCCA) incidence worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Geller, L. T., Barzily-Rokni, M., Danino, T., Jonas, O. H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z. A., Shee, K., et al. (2017) · Science · doi:10.1126/science.aah5043 · Cited by 1,817
Razumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Self-citationGuidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Self-citationTodani, T., Watanabe, Y., Narusue, M., Tabuchi, K., & Okajima, K. (1977) · The American Journal of Surgery · doi:10.1016/0002-9610(77)90359-2 · Cited by 1,451
Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S., & Schilsky, M. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60196-2 · Cited by 1,446
Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Ilyas, S. I., & Gores, G. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.013 · Cited by 1,307
Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution
DeOliveira, M. L., Cunningham, S. C., Cameron, J. L., Kamangar, F., Winter, J. M., Lillemoe, K. D., Choti, M. A., Yeo, C. J., & Schulick, R. D. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251366.62632.d3 · Cited by 1,300
Cholangiocarcinoma: A Spectrum of Intrahepatic, Perihilar, and Distal Tumors
Nakeeb, A., Pitt, H. A., Sohn, T. A., Coleman, J., Abrams, R. A., Piantadosi, S., Hruban, R. H., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00005 · Cited by 1,187
Epidemiology of Hepatocellular Carcinoma: Consider the Population
Mittal, S., & El-Serag, H. B. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182872f29 · Cited by 1,076
Risk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
Overview: how is alcohol metabolized by the body?
(2006) · PubMed Central · Cited by 813
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
Saha, S. K., Zhu, A. X., Fuchs, C. S., & Brooks, G. A. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0446 · Cited by 786
Liver Fluke Induces Cholangiocarcinoma
Sripa, B., Kaewkes, S., Sithithaworn, P., Mairiang, E., Laha, T., Smout, M., Pairojkul, C., Bhudhisawasdi, V., Tesana, S., Thinkamrop, B., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040201 · Cited by 775
Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis
Allen, K. J., Gurrin, L. C., Constantine, C. C., Osborne, N. J., Delatycki, M. B., Nicoll, A. J., McLaren, C. E., Bahlo, M., Nisselle, A. E., Vulpe, C. D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073286 · Cited by 731
Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
Shaib, Y. H., Davila, J. A., McGlynn, K., & El-Serag, H. B. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.030 · Cited by 683
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
Khan, S. A., Taylor-Robinson, S. D., Toledano, M. B., Beck, A., Elliott, P., & Thomas, H. C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00297-0 · Cited by 570
Self-citationWelzel, T. M., Graubard, B. I., Zeuzem, S., El-Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 543
Understanding the role of gut microbiome–host metabolic signal disruption in health and disease
Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.05.006 · Cited by 541
Hepatocellular carcinoma epidemiology
Bosetti, C., Turati, F., & La Vecchia, C. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.08.007 · Cited by 530
Palmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
Welzel, T. M., Graubard, B. I., El–Serag, H. B., Shaib, Y. H., Hsing, A. W., Davila, J. A., & McGlynn, K. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.020 · Cited by 514
Worldwide trends in mortality from biliary tract malignancies
Patel, T. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-10 · Cited by 491
Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia
Schottenfeld, D., & Beebe-Dimmer, J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.69 · Cited by 475
Epidemiology of cholangiocarcinoma: An update focusing on risk factors
Shin, H., Oh, J., Masuyer, E., Curado, M., Bouvard, V., Fang, Y., Wiangnon, S., Sripa, B., & Hong, S. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01458.x · Cited by 454
Axelrad, J. E., Lichtiger, S., & Yajnik, V. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i20.4794 · Cited by 431
Iron, hemochromatosis, and hepatocellular carcinoma
Kowdley, K. V. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.019 · Cited by 391
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998
Taylor-Robinson, S. D., Toledano, M. B., Arora, S., Keegan, T. J., Hargreaves, S., Beck, A., Khan, S. A., Elliott, P., & Thomas, H. C. (2001) · Gut · doi:10.1136/gut.48.6.816 · Cited by 381
Self-citationWelzel, T. M., McGlynn, K. A., Hsing, A. W., O'Brien, T. R., & Pfeiffer, R. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj234 · Cited by 372
Hainsworth, J. D., Rubin, M. S., Spigel, D. R., Boccia, R. V., Raby, S., Quinn, R., & Greco, F. A. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.3755 · Cited by 362
El‐Serag, H. B., Engels, E. A., Landgren, O., Chiao, E., Henderson, L., Amaratunge, H. C., & Giordano, T. P. (2009) · Hepatology · doi:10.1002/hep.22606 · Cited by 313
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
Khan, S. A., Emadossadaty, S., Ladep, N. G., Thomas, H. C., Elliott, P., Taylor-Robinson, S. D., & Toledano, M. B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.015 · Cited by 290
Self-citationPetrick, J. L., Campbell, P. T., Koshiol, J., Thistle, J. E., Andreotti, G., Beane-Freeman, L. E., Buring, J. E., Chan, A. T., Chong, D. Q., Doody, M. M., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0007-z · Cited by 257
Donato, F., Gelatti, U., Tagger, A., Favret, M., Ribero, M. L., Callea, F., Martelli, C., Savio, A., Trevisi, P., & Nardi, G. (2001) · Cancer Causes & Control · doi:10.1023/a:1013747228572 · Cited by 247
Sternlieb, I. (1980) · Gastroenterology · doi:10.1016/s0016-5085(19)30524-4 · Cited by 240
Roles of liver fluke infection as risk factor for cholangiocarcinoma
Sithithaworn, P., Yongvanit, P., Duenngai, K., Kiatsopit, N., & Pairojkul, C. (2014) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.62 · Cited by 231
Patel, T. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0389 · Cited by 224
Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study
Lee, T. Y., Lee, S. S., Jung, S. W., Jeon, S. H., Yun, S.-C., Oh, H.-C., Kwon, S., Lee, S. K., Seo, D. W., Kim, M.-H., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01796.x · Cited by 217
Petrick, J. L., Yang, B., Altekruse, S. F., Van Dyke, A. L., Koshiol, J., Graubard, B. I., & McGlynn, K. A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186643 · Cited by 210
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
Sanna, C., Rosso, C., Marietti, M., & Bugianesi, E. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050717 · Cited by 194
Söreide, K., Körner, H., Havnen, J., & Söreide, J. A. (2004) · British Journal of Surgery · doi:10.1002/bjs.4815 · Cited by 193
Translocation pathways for inhaled asbestos fibers
Miserocchi, G., Sancini, G., Mantegazza, F., & Chiappino, G. (2008) · Environmental Health · doi:10.1186/1476-069x-7-4 · Cited by 181
Honjo, S., Srivatanakul, P., Sriplung, H., Kikukawa, H., Hanai, S., Uchida, K., Todoroki, T., Jedpiyawongse, A., Kittiwatanachot, P., Sripa, B., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21146 · Cited by 180
Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies
Dodson, R. M., Weiss, M. J., Cosgrove, D., Herman, J. M., Kamel, I., Anders, R., Geschwind, J.-F. H., & Pawlik, T. M. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2013.05.021 · Cited by 165
Saich, R., & Chapman, R. W. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.331 · Cited by 161
Chaiteerakij, R., Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Mettler, T. A., Fredericksen, Z. S., Kim, W. R., Gores, G. J., Roberts, R. O., Olson, J. E., et al. (2012) · Hepatology · doi:10.1002/hep.26092 · Cited by 153
Hepatolithiasis and intrahepatic cholangiocarcinoma: A review
Kim, H. J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i48.13418 · Cited by 152
Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis
Jing, W., Jin, G., Zhou, X., Zhou, Y., Zhang, Y., Shao, C., Liu, R., & Hu, X. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283481d89 · Cited by 146
Zhou, H., Rogler, L. E., Teperman, L. W., Morgan, G., & Rogler, C. E. (2007) · Hepatology · doi:10.1002/hep.21557 · Cited by 144
Bertuccio, P., Bosetti, C., Levi, F., Decarli, A., Negri, E., & Vecchia, C. L. (2013) · Annals of Oncology · doi:10.1093/annonc/mds652 · Cited by 140
Lee, C. H., Chang, C. J., Lin, Y.-H., Yeh, C.-N., Chen, M. F., & Hsieh, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605063 · Cited by 138
Wongjarupong, N., Assavapongpaiboon, B., Susantitaphong, P., Cheungpasitporn, W., Treeprasertsuk, S., Rerknimitr, R., & Chaiteerakij, R. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0696-4 · Cited by 136
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms
Melum, E., Karlsen, T. H., Schrumpf, E., Bergquist, A. M., Thorsby, E., Boberg, K. M., & Lie, B. A. (2007) · Hepatology · doi:10.1002/hep.21964 · Cited by 134
Descriptive Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea
Shin, H., Oh, J., Lim, M. K., Shin, A., Kong, H., Jung, K., Won, Y., Park, S., Park, S., & Hong, S. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.7.1011 · Cited by 122
Polymorphism of glutathione S-transferase Omega gene and risk of cancer
Marahatta, S. B., Punyarit, P., Bhudisawasdi, V., Paupairoj, A., Wongkham, S., & Petmitr, S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.020 · Cited by 113
Metal-mediated DNA damage and cell death: mechanisms, detection methods, and cellular consequences
Angelé-Martínez, C., Goodman, C., & Brumaghim, J. L. (2014) · Metallomics · doi:10.1039/c4mt00057a · Cited by 112
Zhou, Y., Zhao, Y., Li, B., Huang, J., Wu, L., Xu, D., Yang, J., & He, J. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-289 · Cited by 107
Hepatobiliary malignancies in Wilson disease
Pfeiffenberger, J., Mogler, C., Gotthardt, D. N., Schulze‐Bergkamen, H., Litwin, T., Reuner, U., Hefter, H., Hüster, D., Schemmer, P., Członkowska, A., et al. (2014) · Liver International · doi:10.1111/liv.12727 · Cited by 102
New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin
Bragazzi, M. C., Ridola, L., Safarikia, S., Matteo, S. D., Costantini, D., Nevi, L., & Cardinale, V. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0209 · Cited by 100
Incidence Rates of Intra- and Extrahepatic Cholangiocarcinomas in Denmark From 1978 Through 2002
Jepsen, P., Vilstrup, H., Tarone, R. E., Friis, S., & Sørensen, H. T. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk201 · Cited by 95
Staretz, M. E., Murphy, S. E., Patten, C., Nunes, M. G., Koehl, W., Amin, S., Koenig, L. A., Guengerich, F. P., & Hecht, S. S. (1997) · PubMed · Cited by 90
Sørensen, J. Ø., Nielsen, O. H., Andersson, M., Ainsworth, M. A., Ytting, H., Bélard, E., & Jess, T. (2017) · Liver International · doi:10.1111/liv.13548 · Cited by 90
Li, M., Li, J., Li, P., Li, H., Su, T., Zhu, R., & Gong, J. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07207.x · Cited by 88
Chang, J. S.-M., Tsai, C., & Chen, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069981 · Cited by 85
Wilson's disease and hepatocellular carcinoma: possible protective role of copper.
Wilkinson, M., Portmann, B., & Williams, R. L. (1983) · Gut · doi:10.1136/gut.24.8.767 · Cited by 81
Altekruse, S. F., Petrick, J. L., Rolin, A. I., Cucinelli, J. E., Zou, Z., Tatalovich, Z., & McGlynn, K. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120574 · Cited by 79
Trends in the incidence and management of biliary tract cancer: A French population-based study
Lepage, C., Cottet, V., Chauvenet, M., Phelip, J., Bedenne, L., Faivre, J., & Bouvier, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.039 · Cited by 79
Erichsen, R., Jepsen, P., Vilstrup, H., Ekbom, A., & Sørensen, H. T. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9365-4 · Cited by 74
Li, H., Hu, B., Zhou, Z., Guan, J., Zhang, Z., & Zhou, G.-W. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0583-9 · Cited by 71
The inhibitory effect of copper on DL-ethionine carcinogenesis in rats.
Kamamoto, Y., Makiura, S., Sugihara, S., Hiasa, Y., & Arai, M. (1973) · PubMed · Cited by 70
Gastrointestinal cancers in inflammatory bowel disease: An update with emphasis on imaging findings
Barral, M., Dohan, A. J. J., Allez, M., Boudiaf, M., Camus, M., Laurent, V., Hoeffel, C. C., & Soyer, P. A. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.005 · Cited by 69
Brandi, G., Girolamo, S. D., Farioli, A., Rosa, F. D., Curti, S., Pinna, A. D., Ercolani, G., Violante, F. S., Biasco, G., & Mattioli, S. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0167-3 · Cited by 61
Self-citationHuai, J., Ding, J. W., Ye, X., & Chen, Y. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3477 · Cited by 60
Cancer Attributable to Asbestos Exposure in Shipbreaking Workers: A Matched-Cohort Study
Wu, W., Lin, Y.-J., Li, C., Tsai, P., Yang, C., Liou, S., & Wu, T.-N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133128 · Cited by 59
Relation of hepatolithiasis to helminthic infestation
Huang, M., CHEN, C., Yen, C., Yang, J.-C., Yang, C., Yeh, Y., Chou, D., Yueh, S.-K., YANG, Y., & Nien, C. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03523.x · Cited by 57
Primary Liver Carcinoma in Genetic Hemochromatosis Reveals a Broad Histologic Spectrum
Morcos, M., Dubois, S., Bralet, M., Belghiti, J., Degott, C., & Terris, B. (2001) · American Journal of Clinical Pathology · doi:10.1309/2rfk-hd06-a788-1fjh · Cited by 54
Liu, Z., Zhou, Y., Shi, L., & Yin, Z. (2011) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(11)60106-9 · Cited by 53
Combined hepatocellular cholangiocarcinoma: Controversies to be addressed
Wang, A.-Q. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i18.4459 · Cited by 53
Sripa, B., Deenonpoe, R., & Brindley, P. J. (2016) · Parasitology International · doi:10.1016/j.parint.2016.11.016 · Cited by 52
Obesity and the risk of cholangiocarcinoma: a meta-analysis
Li, J.-S., Han, T., Jing, N., Li, L., Zhang, X., Ma, F.-Z., & Liu, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-1939-4 · Cited by 50
Reddy, S. K., Hyder, O. N., Marsh, J. W., Sotiropoulos, G. C., Paul, A., Alexandrescu, S. T., Marques, H. P., Pulitanò, C., Barroso, E., Aldrighetti, L. A., et al. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2149-x · Cited by 46
Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification
Walter, D. H., Ferstl, P. G., Waidmann, O., Trojan, J., Hartmann, S., Schnitzbauer, A. A., Zeuzem, S., & Kraywinkel, K. (2018) · Liver International · doi:10.1111/liv.13954 · Cited by 45
The role of the hepatitis viruses in cholangiocarcinoma
Ralphs, S., & Khan, S. A. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12093 · Cited by 44
Self-citationSmoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: A meta-analysis
Ye, X. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i46.8780 · Cited by 43
Prawan, A., Kukongviriyapan, V., Tassaneeyakul, W., Pairojkul, C., & Bhudhisawasdi, V. (2005) · European Journal of Cancer Prevention · doi:10.1097/00008469-200506000-00008 · Cited by 43
Monolobar Caroli′s Disease and Cholangiocarcinoma
Abdalla, E. K., Forsmark, C. E., Lauwers, G. Y., & Vauthey, J. (1999) · HPB Surgery · doi:10.1155/1999/70985 · Cited by 43
Kinoshita, M., Kubo, S., Tanaka, S., Takemura, S., Nishioka, T., Hamano, G., Ito, T., Tanaka, S., Ohsawa, M., & Shibata, T. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24223 · Cited by 43
Kumagai, S., Sobue, T., Makiuchi, T., Kubo, S., Uehara, S., Hayashi, T., Satō, K., & Endo, G. (2016) · Occupational and Environmental Medicine · doi:10.1136/oemed-2015-103427 · Cited by 43
Farioli, A., Straíf, K., Brandi, G., Curti, S., Kjærheim, K., Martinsen, J. I., Sparén, P., Tryggvadóttír, L., Weiderpass, E., Biasco, G., et al. (2017) · Occupational and Environmental Medicine · doi:10.1136/oemed-2017-104603 · Cited by 43
Self-citationIncreased risk of death in thorotrast-exposed patients during the late follow-up period.
Kato, I., & Kido, C. (1987) · PubMed · Cited by 42
Ishikawa, Y., Wada, I., & Fukumoto, M. (2001) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.v20.i4.70 · Cited by 42
Ellervik, C., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02404.x · Cited by 37
Höblinger, A., Grünhage, F., Sauerbruch, T., & Lammert, F. (2009) · Digestion · doi:10.1159/000212990 · Cited by 37
Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers
Kilander, C., Mattsson, F., Ljung, R., Lagergren, J., & Sadr‐Azodi, O. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.857429 · Cited by 37
Boulanger, M., Morlais, F., Bouvier, V., Galateau-Sallé, F., Guittet, L., Marquignon, M.-F., Paris, C., Raffaelli, C., Launoy, G. D., & Clin, B. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2015-102871 · Cited by 36
Obesity and cholangiocarcinoma
Parsi, M. A. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i4.457 · Cited by 35
Ishikawa, Y., Wada, I., & Fukumoto, M. (2001) · PubMed · Cited by 29
Helicobacter Species are Possible Risk Factors of Cholangiocarcinoma
Kaewpitoon, S. J., Loyd, R. A., Rujirakul, R., Panpimanmas, S., Matrakool, L., Tongtawee, T., Kootanavanichpong, N., Pengsaa, P., Kompor, P., Chavengkun, W., et al. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.1.37 · Cited by 24
Sulpice, L., Rayar, M., Boucher, É., Pelé, F., Pracht, M., Meunier, B., & Boudjéma, K. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.10.051 · Cited by 22
Asbestos fibers in the gallbladder of patients affected by benign biliary tract diseases
Grosso, F., Randi, L., Croce, A., Mirabelli, D., Libener, R., Magnani, C., Bellis, D., Allegrina, M., Bertolotti, M., Degiovanni, D., et al. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000357 · Cited by 20
Nkontchou, G., Nhieu, J. T. V., Ziol, M., Tengher-Barna, I., Mahmoudi, A., Roulot, D. M., Bourcier, V., Ganne‐Carrié, N., Grando–Lemaire, V., Trinchet, J., et al. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328357cdd7 · Cited by 20
MYH rs3219476 and rs3219472 polymorphisms and risk of cholangiocarcinoma
You, S., Wang, X., Huang, S.-C., Wang, M., Ji, G., Jin-rong, X., & Fan, Z. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1175 · Cited by 14
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationBrindley, P. J., Bachini, M., Ilyas, S. I., Khan, S. A., Loukas, A., Sirica, A. E., Teh, B. T., Wongkham, S., & Gores, G. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00300-2 · Cited by 841
Self-citationIron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Vogel, A., Bridgewater, J., Edeline, J., Kelley, R. K., Klümpen, H. J., Malka, D., Primrose, J. N., Rimassa, L., Stenzinger, A., Valle, J. W., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2022.10.506 · Cited by 718
Moris, D., Palta, M., Kim, C., Allen, P. J., Morse, M. A., & Lidsky, M. E. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21759 · Cited by 451
Metadata
- Authors
- Khan, S. A., Tavolari, S., & Brandi, G.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2019-03-24
- Volume
- 39
- Issue
- S1
- Pages
- 19-31
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2920849174
- Cited by
- 783
- References
- 105
- FWCI
- 70.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.